Internal Medicine - Issue 6/2021
Editorial
Main Topic
323
328
Inhaled glucocorticoids in treatment of covid-19
Milan Sova, Ondřej Zela
330
Review Articles
334
Anti-cancer therapy-induced metabolic syndrome
Eva Řiháčková, Lubomír Elbl, Michal Řiháček, Mária Holická, Petr Kala
339
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) Part I. Pathophysiology, clinical symptoms and recommend screening for vascular malformations
Zdeněk Adam, Dagmar Brančiková, Gabriela Romanová, Luděk Pour, Marta Krejčí, Jiří König, Tomáš Nebeský, Zuzana Adamová, Martin Štork, Martin Krejčí, Sabina Ševčíková, Michal Eid, Zdeněk Král
346
Case reports
352
Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone
Zdeněk Adam, Luděk Pour, Zdeněk Řehák, Klára Dvořáková, Renata Koukalová, Josef Feit, Petr Kameník, Marta Krejčí, Martin Štork, Martin Krejčí, Viera Sandecká, Ivanna Boichuk, Zdeněk Král
357
Localised forms of pulmonary amyloidosis
Eva Mnacakanová, Lenka Henzlová, MUDr. Pavla Flodrová, Ph.D., Tomáš Pika
In Brief
366
Screening for gestational diabetes mellitus
Kateřina Anderlová
368
Why we still don’t achieve blood pressure targets
Vladimír Tuka, Aleš Linhart
Internal Medicine
2021 Issue 6
Most read in this issue
- Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) Part I. Pathophysiology, clinical symptoms and recommend screening for vascular malformations
- Localised forms of pulmonary amyloidosis
- Respiratory insufficiency, chronic hypercapnia and domiciliary non-invasive ventilation from the point of view of a pneumologist
- Screening for gestational diabetes mellitus